Cardiology
Conference Coverage
Alirocumab’s ODYSSEY continues: Efficacy unaffected by insulin, beats fenofibrate
LISBON – Lipids in either type of diabetes may have met their match.
Conference Coverage
VIDEO: What’s new in AAP’s pediatric hypertension guidelines
SAN FRANCISCO – Some of the advice is similar to the group’s last effort in 2004, but there are a few key changes.
From the Journals
Patent foramen ovale closure reduces risk of stroke in three trials
Risks of procedure must be weighed against the benefit of reduced stroke risk.
From the Journals
New data prompt update to ACC guidance on nonstatin LDL lowering
The ACC has updated its advice regarding the use of nonstatin therapies following clinical trial results of PCSK9 inhibitors and ezetimibe.
From the Journals
No increased overall cardiovascular risk seen with exenatide use
Patients with type 2 diabetes who took once-daily exenatide did not appear to have an increase in their overall cardiovascular risk, compared with...
Conference Coverage
Older men benefit from vascular screening
BARCELONA – Vascular screening led to 7% lower mortality in older men compared, compared with controls.
From the Journals
Metabolically healthy obese still at elevated cardiovascular risk
Fat is not benign, according to a U.K. study of 3.5 million people.
News from the FDA/CDC
Recent upturn seen in stroke death rate
Long-term decline ended in 2013; reasons for the reversal “are not clear.”
Conference Coverage
Ivabradine cut mortality in HFrEF patients not on beta-blocker
BARCELONA – Secondary analysis of SHIFT trial suggests potential expanded role for heart failure agent.
From the Journals
Statin use cuts risks in compensated cirrhosis
Hepatic decompensation and mortality dropped 46% in patients with compensated cirrhosis of any etiology.
Guidance for Practicing Primary Care
Management of adults with syncope
Primary care providers should expect to have to undertake the initial evaluation of syncope in their offices. Not all fainters go to the ED.